Official Name:
- RU: Больница Гуанчжоу Фосунь Чаньчэн (бывшая больница «Синши» Гуандунского фармацевтического университета)
- EN: Guangzhou Fosun Chancheng Hospital (Xinshi Hospital) of Guangdong Pharmaceutical University
- CN: 广州复星禅诚医院（新市医院）
Country, City, Address: China, Guangdong Province, Guangzhou City, Baiyun District, No. 79 Xinshi Xinjie (No. 79 Xinshi Xinjie, Baiyun District, Guangzhou). Nearest airport: Guangzhou Baiyun (CAN), ~25–30 km, 30–40 minutes by car.
Year of Establishment: 2003 (confirmed). Joined Fosun Health Group in 2021.
Type of Clinic: Private multi-specialty tertiary-level hospital (Grade III) combining clinical care, teaching, research, and prevention. Affiliated with Guangdong Pharmaceutical University. Over 40 clinical departments; planned bed capacity: 800.
Main Specializations:
| Specialty | Details |
|---|---|
| Oncology | Flagship department — International Center for Minimally Invasive Tumor Diagnosis and Treatment. 17,000+ patients in 2024. Cryotherapy, radiofrequency ablation, iodine seed implantation, vascular interventional therapy |
| Minimally Invasive Surgery | One of the hospital's three key profiles |
| Neurology & Neurosurgery | Third key profile — neuroscience center; treatment of brain tumors, stroke, epilepsy |
| Cardiology | Establishing a national chest pain center |
| Gastroenterology | Among the developing disciplines |
| Urology | Developing within a multi-specialty framework |
| Traditional Chinese Medicine | Integrated into clinical pathways, including oncology |
| Obstetrics & Gynecology | Part of the multi-specialty hospital |
Key Technologies:
- Minimally Invasive Tumor Ablation — cryotherapy, radiofrequency ablation (RFA), iodine seed implantation (brachytherapy), vascular interventional therapy. Procedures take ~30 minutes under local anesthesia; suitable for elderly and frail patients.
- CAR-T Therapy for Solid Tumors — Kailimei® (satricel autoleucel, code CT041), the world's first approved CAR-T product for solid tumors. The hospital is among the first in China to receive regulatory certification for clinical use. The first patient (gastric cancer) underwent cell collection in 2026.
- Multidisciplinary Team (MDT) Model — cross-disciplinary consultations for complex cases.
- Integration of TCM and Western Medicine — approach of the oncology center.
- NK Cell Screening for Early Cancer Detection — part of the International Center for Minimally Invasive Diagnosis.
Conditions Treated:
| Condition Group | Specific Diagnoses |
|---|---|
| Oncology — Minimally Invasive Ablation | Liver cancer, lung cancer, kidney tumors, bone metastases, selected pancreatic cancer cases, soft tissue tumors, recurrent tumors after surgery/radiotherapy |
| CAR-T (Solid Tumors) | Advanced gastric cancer and gastroesophageal junction adenocarcinoma (CLDN18.2-positive, HER2-negative), progressed after 2+ lines of therapy |
| Neurology | Brain tumors, stroke, epilepsy, neurodegenerative diseases |
| Cardiology | Chest pain (national center), arrhythmia, coronary artery disease |
| Gastroenterology | Gastrointestinal disorders |
| Urology | Urologic conditions |
| Orthopedics | Minimally invasive orthopedic surgery |
| Obstetrics/Gynecology | Part of the multi-specialty hospital |
International Center: Yes. The International Medical Center was officially opened in March 2025. Located on the 5th floor of Building 5, with an area of ~1,500 sq. m: consultation zones, expert evaluation rooms, private treatment wards, and VIP rooms. The hospital holds the status of a National Pilot Demonstration Base for International Medical Tourism. Services: medical visa support, direct insurance coverage, cross-border teleconsultations, bilateral referrals. Fosun Health has representative offices in Hong Kong, Indonesia, Bangladesh, and Vietnam.
Languages: Chinese (primary). Multilingual support: English, Japanese, Indonesian, and other languages through the International Center. No direct Russian-language service has been confirmed; Russian-speaking patient coordination is handled through third-party platforms.
Doctors / Leading Specialists:
| Name | Position | Experience |
|---|---|---|
| Prof. Chen Tao | Director, International Medical Center | Leads the solid-tumor CAR-T program; oversees international patients |
| Dr. Wu Yanxian | Director, Cardiology Department | Heads the cardiology service; cited in Fosun Health publications |
| Dr. Song Guangyi | Chief Physician, Medical Imaging | Professor |
| Dr. Wang Dianchun | Director, Neurosurgery Department | |
| Dr. Feng Xiaobo | Chief Physician, Vascular Surgery | |
| Prof. Xu Zhiqiang | Oncology; Professor, doctoral supervisor | |
| Dr. Li Cheng | Deputy Chief Physician, General Surgery | |
| Dr. Liu Ming | Chief Physician, Orthopedics |
The CAR-T therapy team is led by two oncologists with postdoctoral training at Harvard and dual certification (China + US).
Equipment:
| Equipment | Purpose |
|---|---|
| Cryotherapy System | Cryoablation of solid tumors |
| Radiofrequency Ablation (RFA) System | Local tumor destruction |
| Iodine Seed Implantation System | Brachytherapy — interstitial radiation |
| Vascular Interventional System | Embolization, chemoembolization of tumors |
| Comprehensive Diagnostic Imaging | CT, MRI, Ultrasound — navigation for ablation procedures |
| NK Cell Screening Equipment | Early cancer detection |
Important note: CyberKnife M6 and Da Vinci surgical robot belong to the Foshan hospital, not the Guangzhou facility. For the Guangzhou hospital, specific models of linear accelerators and surgical robots have not been confirmed in public sources.
Photographs: Available on the official hospital website and the Fosun Health portal.
Official Website:
- Hospital: https://gzfxccyy.com/
- Fosun Health portal:https://hospitals.fosunhealth.com/about/guangzhoufosun/
Contacts:
- Phone: +86 20-62830543
- Address: No. 79 Xinshi Xinjie, Baiyun District, Guangzhou, Guangdong Province, China
Accreditations & Statuses:
- Grade III comprehensive hospital (confirmed)
- National Pilot Demonstration Base for International Medical Tourism
- Clinical medicine in global top 1% ESI (through affiliation with Guangdong Pharmaceutical University)
- Within Fosun Health network: ISO 15189 and ISO 9001 (network-wide certification)
- JCI (network-wide certification)
The date of the last information check: 06.10.2026.
Obstetrics and Gynecology
Cardiology
Oncology
Orthopedics
Urology
